More on Trinity Biotech Q2 results

|About: Trinity Biotech PLC (TRIB)|By:, SA News Editor

Trinity Biotech (TRIB +0.7%) Q2 results: Revenues: $26.0M (+22.1%); Operating Income: $4.6M (+24.3%); Net Income: $4.3M (+13.2%); Earnings per ADR: $0.182 (+7.7%); Quick Assets: $15.2M (-10.6%); CF Ops: $1.6M (-23.8%).

106 Premier instruments placed or sold, 207 in 1H. FY Goal: 460.

No guidance given.